134 related articles for article (PubMed ID: 29522880)
21. Transcriptome Profiling Reveals Interplay of Multifaceted Stress Response in
Goswami M; Narayana Rao AVSS
mSystems; 2018; 3(1):. PubMed ID: 29468195
[TBL] [Abstract][Full Text] [Related]
22. Roles of the glutathione- and thioredoxin-dependent systems in the Escherichia coli responses to ciprofloxacin and ampicillin.
Smirnova G; Muzyka N; Lepekhina E; Oktyabrsky O
Arch Microbiol; 2016 Nov; 198(9):913-21. PubMed ID: 27277520
[TBL] [Abstract][Full Text] [Related]
23. De Novo Characterization of Genes That Contribute to High-Level Ciprofloxacin Resistance in Escherichia coli.
Tran T; Ran Q; Ostrer L; Khodursky A
Antimicrob Agents Chemother; 2016 Oct; 60(10):6353-5. PubMed ID: 27431218
[TBL] [Abstract][Full Text] [Related]
24. Involvement of Antibiotic Efflux Machinery in Glutathione-Mediated Decreased Ciprofloxacin Activity in Escherichia coli.
Goswami M; Subramanian M; Kumar R; Jass J; Jawali N
Antimicrob Agents Chemother; 2016 Jul; 60(7):4369-74. PubMed ID: 27139480
[TBL] [Abstract][Full Text] [Related]
25. DNA gyrase and topoisomerase IV on the bacterial chromosome: quinolone-induced DNA cleavage.
Chen CR; Malik M; Snyder M; Drlica K
J Mol Biol; 1996 May; 258(4):627-37. PubMed ID: 8636997
[TBL] [Abstract][Full Text] [Related]
26. [Active efflux of antibiotics as multiple-antibiotic-resistance mechanism in clinical strains of escherichia coli].
Zhang X; Li J
Zhonghua Yi Xue Za Zhi; 2000 Aug; 80(8):614-7. PubMed ID: 11798829
[TBL] [Abstract][Full Text] [Related]
27. Experimental intravitreal application of ciprofloxacin in rabbits.
Wiechens B; Grammer JB; Johannsen U; Pleyer U; Hedderich J; Duncker GI
Ophthalmologica; 1999; 213(2):120-8. PubMed ID: 9885389
[TBL] [Abstract][Full Text] [Related]
28. Involvement of reactive oxygen species in the action of ciprofloxacin against Escherichia coli.
Goswami M; Mangoli SH; Jawali N
Antimicrob Agents Chemother; 2006 Mar; 50(3):949-54. PubMed ID: 16495256
[TBL] [Abstract][Full Text] [Related]
29. Emergence of a new mutation and its accumulation in the topoisomerase IV gene confers high levels of resistance to fluoroquinolones in Escherichia coli isolates.
Moon DC; Seol SY; Gurung M; Jin JS; Choi CH; Kim J; Lee YC; Cho DT; Lee JC
Int J Antimicrob Agents; 2010 Jan; 35(1):76-9. PubMed ID: 19781915
[TBL] [Abstract][Full Text] [Related]
30. Comparative Proteomics of Commensal and Pathogenic Strains of
Singhal N; Sharma D; Kumar M; Bisht D; Virdi JS
Protein Pept Lett; 2020; 27(11):1171-1177. PubMed ID: 32416668
[TBL] [Abstract][Full Text] [Related]
31. Characterization of Escherichia coli isolates from healthy food handlers in hospital.
Luo Y; Cui S; Li J; Yang J; Lin L; Hu C; Jin S; Ye L; Zhao Q; Ma Y
Microb Drug Resist; 2011 Sep; 17(3):443-8. PubMed ID: 21612511
[TBL] [Abstract][Full Text] [Related]
32. Fluoroquinolone resistance in clinical and environmental isolates of Escherichia coli in Mexico City.
Amábile-Cuevas CF; Arredondo-García JL; Cruz A; Rosas I
J Appl Microbiol; 2010 Jan; 108(1):158-62. PubMed ID: 19548885
[TBL] [Abstract][Full Text] [Related]
33. Increased expression of Qnr is sufficient to confer clinical resistance to ciprofloxacin in Escherichia coli.
Garoff L; Yadav K; Hughes D
J Antimicrob Chemother; 2018 Feb; 73(2):348-352. PubMed ID: 29106520
[TBL] [Abstract][Full Text] [Related]
34. Clonal relationship between human and avian ciprofloxacin-resistant Escherichia coli isolates in North-Eastern Algeria.
Agabou A; Lezzar N; Ouchenane Z; Khemissi S; Satta D; Sotto A; Lavigne JP; Pantel A
Eur J Clin Microbiol Infect Dis; 2016 Feb; 35(2):227-34. PubMed ID: 26634353
[TBL] [Abstract][Full Text] [Related]
35. Proteomic Investigation of Tolerant
Sulaiman JE; Lam H
J Proteome Res; 2020 Feb; 19(2):900-913. PubMed ID: 31920087
[TBL] [Abstract][Full Text] [Related]
36. Escherichia coli cells resistant to the DNA gyrase inhibitor, ciprofloxacin, overproduce a 60 kD protein homologous to GroEL.
Hallett P; Mehlert A; Maxwell A
Mol Microbiol; 1990 Mar; 4(3):345-53. PubMed ID: 1972534
[TBL] [Abstract][Full Text] [Related]
37. The effect of 20-hydroxyecdysone on the susceptibility of Escherichia coli to different antibiotics.
Smirnova G; Bezmaternykh K; Oktyabrsky ON
J Appl Microbiol; 2016 Dec; 121(6):1511-1518. PubMed ID: 27681346
[TBL] [Abstract][Full Text] [Related]
38. Essential Paralogous Proteins as Potential Antibiotic Multitargets in Escherichia coli.
Hardy CD
Microbiol Spectr; 2022 Dec; 10(6):e0204322. PubMed ID: 36445138
[TBL] [Abstract][Full Text] [Related]
39. Global proteomic responses of Escherichia coli and evolution of biomarkers under tetracycline stress at acid and alkaline conditions.
Yang M; Qin H; Wang W; Zhang H; Long Y; Ye J
Sci Total Environ; 2018 Jun; 627():1315-1326. PubMed ID: 30857095
[TBL] [Abstract][Full Text] [Related]
40. Greater ciprofloxacin tolerance as a possible selectable phenotype underlying the pandemic spread of the H30 subclone of Escherichia coli sequence type 131.
Johnson JR; Porter SB; Thuras P; Johnson TJ; Price LB; Tchesnokova V; Sokurenko EV
Antimicrob Agents Chemother; 2015 Nov; 59(11):7132-5. PubMed ID: 26324269
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
